Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

Por van Sandick, J W, van Lanschot, J J B, Kuiken, B, Tytgat, G, Offerhaus, G, Obertop, H
Publicado em 1998

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission

Por Grotenhuis, B.A., Wijnhoven, B.P.L., Hermans, J.J., Biermann, K., van Lanschot, J.J.B.
Publicado em 2009

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

Por Tuynman, J B, Lagarde, S M, ten Kate, F J W, Richel, D J, van Lanschot, J J B
Publicado em 2008

Epithelial cells in bone marrow: do they matter?

Por Marsman, W A, Westerterp, M, van Heek, N J, ten Kate, F J, Izbicki, J R, van Lanschot, J J B
Publicado em 2005

Radiological evaluation of colorectal anastomoses

Por Doeksen, A., Tanis, P. J., Wüst, A. F. J., Vrouenraets, B. C., van Lanschot, J. J. B., van Tets, W. F.
Publicado em 2008

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

Por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2011

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

Por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2012

A “crackleware” oesophagus

Por Westerterp, M, Busch, O R C, Bergman, J J G H M, ten Kate, F J W, van Lanschot, J J B
Publicado em 2005

Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus

Por Buskens, C J, Sivula, A, van Rees, B P, Haglund, C, Offerhaus, G J A, van Lanschot, J J B, Ristimäki, A
Publicado em 2003

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer

Por Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.
Publicado em 2010

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences

Por de Boer, A G E M, Stalmeier, P F M, Sprangers, M A G, de Haes, J C J M, van Sandick, J W, Hulscher, J B F, van Lanschot, J J B
Publicado em 2002

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Por Schreurs, L. M. A., Janssens, A. C. J. W., Groen, H., Fockens, P., van Dullemen, H. M., van Berge Henegouwen, M. I., Sloof, G. W., Pruim, J., van Lanschot, J. J. B., Steyerberg, E. W., Plukker, J. Th. M.
Publicado no Ann Surg Oncol (2011)

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study

Por Markar, S. R., Noordman, B. J., Mackenzie, H., Findlay, J. M., Boshier, P. R., Ni, M., Steyerberg, E. W., van der Gaast, A., Hulshof, M. C. C. M., Maynard, N., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., Reynolds, J. V., Van Lanschot, J. J. B., Hanna, G. B.
Publicado no Ann Oncol (2017)